FindTrial
Sign In

PAIN RELIEF USING 0.25 % BUPIVACAINE AND 0.25 % LEVOBUPIVACAINE ON FRACTURE SITE.

COMPARATIVE EVALUATION OF POST OPERATIVE ANALGESIA AND HEMODYNAMIC CHANGES USING 0.25 % BUPIVACAINE AND 0.25 % LEVOBUPIVACAINE IN ZYGOMATICO MAXILLARY COMPLEX FRACTURE .

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045761
Enrollment
40
Registered
2022-09-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: 0.25 % BUPIVACAINE: 0.25 % BUPIVACAINE will be injected after fixation of zygomaticomaxillary complex fractures.post operatively analgesia and hemodynamic parameters will be assessed. C

Sponsors

shivya chopra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: � Patients requiring maxillofacial surgery under general anaesthesia . � Patients with ASA I and ASA II grade .

Exclusion criteria

Exclusion criteria: 1. Medically compromised patients. 2. Pregnant or lactating mothers . 3. Patients who are allergic to 0.25 % bupivacaine or 0.25 % levobupivacaine . 4. Patients not willing to participate in the study .

Design outcomes

Primary

MeasureTime frame
To evaluate post operative analgesia using VAS scaleTimepoint: To evaluate post operative analgesia using Visual Analogue Scale 2 hour , 4 hours post extubation and at the time of intake of rescue analgesic—

Secondary

MeasureTime frame
To evaluate heamodynamic parameters (BP,RR,HR,SPO2)Timepoint: Before injection, 30 mins after injection, 2 hour after extubation, 4 hrs after extubation.—

Countries

India

Contacts

Public Contactsneha setiya

Dr.DY PATIL DENTAL COLLEGE AND HOSPITAL,PIMPRI,PUNE

sneha.setiya@dpu.edu.in9372485121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026